一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Blood >>article
Blood

Blood

IF: 21
Download PDF

Venetoclax enhances T cell–mediated antileukemic activity by increasing ROS production

Published:22 July 2021 DOI: 10.1182/blood.2020009081 PMID: 34292323
Jong Bok Lee,?Dilshad H Khan,?Rose Hurren,?Mingjing Xu,?Yoosu Na,?Hyeonjeong Kang,?Sara Mirali,?Xiaoming Wang,?Marcela Gronda,?Yulia Jitkova,?Neil MacLean,?Andrea Arruda,?Zoe Alaniz,?Marina Y Konopleva,?Michael Andreeff,?Mark D Minden,?Li Zhang,?Aaron D Schimmer

Abstract

Venetoclax, a Bcl-2 inhibitor, in combination with the hypomethylating agent azacytidine, achieves complete remission with or without count recovery in ~70% of treatment-naive elderly patients unfit for conventional intensive chemotherapy. However, the mechanism of action of this drug combination is not fully understood. We discovered that venetoclax directly activated T cells to increase their cytotoxicity against acute myeloid leukemia (AML) in vitro and in vivo. Venetoclax enhanced T-cell effector function by increasing reactive oxygen species generation through inhibition of respiratory chain supercomplexes formation. In addition, azacytidine induced a viral mimicry response in AML cells by activating the STING/cGAS pathway, thereby rendering the AML cells more susceptible to T cell-mediated cytotoxicity. Similar findings were seen in patients treated with venetoclax, as this treatment increased reactive oxygen species generation and activated T cells. Collectively, this study presents a new immune-mediated mechanism of action for venetoclax and azacytidine in the treatment of AML and highlights a potential combination of venetoclax and adoptive cell therapy for patients with AML.

Substances (13)

Materials Related products
Procduct Name CAS Molecular Formula Supplier Price
ABT-199 1257044-40-8 C45H50ClN7O7S 534 suppliers $12.00-$4766.80
ABT-199 1257044-40-8 C45H50ClN7O7S 534 suppliers $12.00-$4766.80
ABT-199 1257044-40-8 C45H50ClN7O7S 534 suppliers $12.00-$4766.80
ABT-199 1257044-40-8 C45H50ClN7O7S 534 suppliers $12.00-$4766.80
ABT-199 1257044-40-8 C45H50ClN7O7S - Inquiry
ABT-199 1257044-40-8 C45H50ClN7O7S - Inquiry
ABT-199 1257044-40-8 - Inquiry
ABT-199 1257044-40-8 - Inquiry
ABT199 1257044-40-8 - Inquiry
ABT199 1257044-40-8 - Inquiry

Similar articles

IF:40.8

Remolding the tumor microenvironment by bacteria augments adoptive T cell therapy in advanced-stage solid tumors

Signal Transduction and Targeted Therapy Zhu, Chaojie,etc Published: 22 November 2024
IF:5.5

Modification of Lipase with Poly(4-acryloylmorpholine) Enhances Solubility and Transesterification Activity in Anhydrous Ionic Liquids

Biomacromolecules Garrett R. Chado , Elijah N. Holland ,etc Published: 1 January 2018
绥棱县| 鄱阳县| 双辽市| 佛教| 元谋县| 盈江县| 邓州市| 蓬莱市| 富阳市| 友谊县| 台江县| 贵溪市| 台南市| 团风县| 台东县| 淄博市| 东方市| 三都| 东辽县| 金沙县| 石楼县| 南澳县| 潼关县| 库尔勒市| 临高县| 安康市| 深州市| 崇礼县| 尉氏县| 永嘉县| 古交市| 和林格尔县| 昆山市| 苍山县| 大洼县| 融水| 乌苏市| 尼勒克县| 黔西| 丹棱县| 黄冈市|